The effect of vitamin D on the improvement of abdominal pai
Phase 3
- Conditions
- Inflammatory Bowel Disease.Noninfective inflammatory bowel disease(K50-K52)
- Registration Number
- IRCT201011075123N1
- Lead Sponsor
- Vice chancellor for research, Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Inflammatory bowel disease; patient and patient's parents satisfaction
Exclusion criteria: Failure to perform tests in all project stages; taking the supplementation incorrectly; patient dissatisfaction for continuation of the project
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical Symptoms. Timepoint: Befor the trial. Method of measurement: Questionnaire.;Severity of disease. Timepoint: Befor the trial. Method of measurement: Questionnaire.
- Secondary Outcome Measures
Name Time Method VIT D. Timepoint: After the trial. Method of measurement: HPLC.;Ca & P. Timepoint: After the trial. Method of measurement: Enzymatic.;Level of serumic Albmin. Timepoint: After the trial. Method of measurement: Enzymatic.;Level of serumic Feritin. Timepoint: After the trial. Method of measurement: chemoluminescence.